FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169314809> ?p ?o ?g. }

• W2169314809 endingPage "612" @default.
• W2169314809 startingPage "608" @default.
• W2169314809 abstract "HomeRadiologyVol. 247, No. 3 PreviousNext Reviews and CommentaryEditorialsNephrogenic Systemic Fibrosis: A Chemical PerspectiveNeil M. Rofsky, A. Dean Sherry, Robert E. LenkinskiNeil M. Rofsky, A. Dean Sherry, Robert E. LenkinskiAuthor Affiliations1From the Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215 (N.M.R., R.E.L.); and Department of Radiology, UT Southwestern Medical School, Dallas, Tex (A.D.S.). Received November 12, 2007; revision requested December 21; revision received January 15, 2008; final version accepted January 29.Address correspondence to N.M.R. (e-mail: [email protected]).Neil M. RofskyA. Dean SherryRobert E. LenkinskiPublished Online:Jun 1 2008https://doi.org/10.1148/radiol.2473071975MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1 Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007; 188: 586–592. Crossref, Medline, Google Scholar2 Leiner T, Herborn CU, Goyen M. Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide. Eur Radiol 2007;17:1921–1923. Crossref, Medline, Google Scholar3 Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 2007;20:179–185. Crossref, Medline, Google Scholar4 Thomson PC, Collidge TA, Mark PB, Traynor JP. Gadolinium contrast may be risky in kidney disease. BMJ 2007;334:1335–1336. Google Scholar5 Kanal E, Broome DR, Martin DR, Thomsen HS. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 2008;246:11–14. Link, Google Scholar6 Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007;245:168–175. Link, Google Scholar7 Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359–2362. Crossref, Medline, Google Scholar8 Marckmann P, Skov L, Rossen K, Heaf JG, Thomsen HS. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007;22:3174–3178. Crossref, Medline, Google Scholar9 Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148–157. Link, Google Scholar10 High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007;56:21–26. Crossref, Medline, Google Scholar11 High WA, Ayers RA, Cowper SE. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007;56:710–712. Crossref, Medline, Google Scholar12 Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999;10:477–484. Crossref, Medline, Google Scholar13 Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007;25:884–899. Crossref, Medline, Google Scholar14 Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990;8:467–481. Crossref, Medline, Google Scholar15 Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999;99:2293–2352. Crossref, Medline, Google Scholar16 Betts RH, Dahlinger OF. The heat and entropy of association of the complex ions formed by EDTA with the lanthanide elements in aqueous solution. Can J Chem 1959;37:91–100. Crossref, Google Scholar17 Choppin GR. The thermodynamics of lanthanide aminopolycarboxylate complexation. Thermochim Acta 1993;227:1–7. Crossref, Google Scholar18 Brucher E. Kinetic stabilities of gadolinium(III) chelates used as MRI contrast agents. In: Krauase H, ed. Contrast agents I. Berlin, Germany: Springer-Verlag, 2002. Google Scholar19 Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 1992;10:641–648. Crossref, Medline, Google Scholar20 Toth E, Vauthey S, Pubanz D, Merbach AE. Water exchange and rotational dynamics of the dimeric gadolinium(III) complex [BO{Gd(DO3A)(H(2)O)}(2)]: a variable-temperature and -pressure (17)O NMR study(1). Inorg Chem 1996;35:3375–3379. Crossref, Medline, Google Scholar21 Wang X, Tianzhu J, Comblin V, Lopez-Mut A, Merciny E, Desreux JF. A kinetic investigation of the lanthanide DOTA chelates: stability and rates of formation and of dissociation of a macrocyclic gadolinium(III) polyaza polycarboxylic MRI contrast agent. Inorg Chem 1992;31:1095–1099. Crossref, Google Scholar22 Laurent S, Elst LV, Copoix F, Muller RN. Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment. Invest Radiol 2001;36:115–122. Crossref, Medline, Google Scholar23 Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006;1:128–137. Crossref, Medline, Google Scholar24 Gibby WA, Gibby KA, Gibby WA. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Invest Radiol 2004;39:138–142. Crossref, Medline, Google Scholar25 White GW, Gibby WA, Tweedle MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006;41:272–278. Crossref, Medline, Google ScholarArticle HistoryPublished in print: 2008 FiguresReferencesRelatedDetailsCited ByBiodistribution, pharmacokinetics and excretion studies of intravenously injected nanoparticles and extracellular vesicles: Possibilities and challengesToreSkotland, Tore GeirIversen, AliciaLlorente, KirstenSandvig2022 | Advanced Drug Delivery Reviews, Vol. 186Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium UseBenjamin Y.C.Cheong, James M.Wilson, Ourania A.Preventza, RajaMuthupillai2022 | Texas Heart Institute Journal, Vol. 49, No. 3Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticlesE. A.Wallnöfer, G. C.Thurner, C.Kremser, H.Talasz, M. M.Stollenwerk, A.Helbok, N.Klammsteiner, K.Albrecht-Schgoer, H.Dietrich, W.Jaschke, P.Debbage2021 | Histochemistry and Cell Biology, Vol. 155, No. 1Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in TumorsLiLiu, DevinO’Kelly, ReganSchuetze, GrahamCarlson, HelingZhou, Mary LynnTrawick, Kevin G.Pinney, Ralph P.Mason2021 | Molecules, Vol. 26, No. 9Manganese(II)-Based Responsive Contrast Agent Detects Glucose-Stimulated Zinc Secretion from the Mouse Pancreas and Prostate by MRISaraChirayil, Veronica ClavijoJordan, André F.Martins, NaminiParanawithana, S. JamesRatnakar, A. DeanSherry2021 | Inorganic Chemistry, Vol. 60, No. 4Biomaterials for Cancer TherapeuticsR.Zeineldin2020MR Imaging Safety Considerations of Gadolinium-Based Contrast AgentsJennifer S.McDonald, Robert J.McDonald2020 | Magnetic Resonance Imaging Clinics of North America, Vol. 28, No. 4Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case ReportYu JeongLim, JisunBang, YoungsunKo, Hyun-MinSeo, Woon YongJung, Joo HarkYi, Sang-WoongHan, Mi-yeonYu2020 | Journal of Korean Medical Science, Vol. 35, No. 35Gadolinium Deposition and Retention in the Brain: Should We Be Concerned?Robert E. Lenkinski, 29 August 2019 | Radiology: Cardiothoracic Imaging, Vol. 1, No. 3Metal-based redox-responsive MRI contrast agentsSara M.Pinto, VanessaTomé, Mário J.F.Calvete, M. Margarida C.A.Castro, ÉvaTóth, Carlos F.G.C.Geraldes2019 | Coordination Chemistry Reviews, Vol. 390Gd3+:DOTA-Modified 2-Hydroxypropyl-β-Cyclodextrin/4-Sulfobutyl Ether-β-Cyclodextrin-Based Polyrotaxanes as Long Circulating High Relaxivity MRI Contrast AgentsYawo A.Mondjinou, Bradley P.Loren, Christopher J.Collins, Seok-HeeHyun, AsherDemoret, JosephSkulsky, CheyenneChaplain, VivekBadwaik, David H.Thompson2018 | Bioconjugate Chemistry, Vol. 29, No. 11Gadolinium Retention and Deposition Revisited: How the Chemical Properties of Gadolinium-based Contrast Agents and the Use of Animal Models Inform Us about the Behavior of These Agents in the Human BrainRobert E. Lenkinski, 20 November 2017 | Radiology, Vol. 285, No. 3Gadolinium Contrast Agents - Are they Really Safe?HanaMalikova, MichalHolesta2017 | The Journal of Vascular Access, Vol. 18, No. 2_supplAnthropogenic gadolinium anomalies and rare earth elements in the water of Atibaia River and Anhumas Creek, Southeast BrazilFrancisco Ferreirade Campos, JacintaEnzweiler2016 | Environmental Monitoring and Assessment, Vol. 188, No. 5Handbook on the Physics and Chemistry of Rare EarthsDavidParker2016 | , Vol. 50Self-reported gadolinium toxicity: A survey of patients with chronic symptomsLauren M.B.Burke, MiguelRamalho, MamdohAlObaidy, EmilyChang, MichaelJay, Richard C.Semelka2016 | Magnetic Resonance Imaging, Vol. 34, No. 8Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium – 1997–2006–2016. Part 1Henrik SThomsen2016 | Acta Radiologica, Vol. 57, No. 5High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast AgentsJoana Ramalho, Mauricio Castillo, Mamdoh AlObaidy, Renato H. Nunes, Miguel Ramalho, Brian M. Dale, Richard C. Semelka, 16 June 2015 | Radiology, Vol. 276, No. 3Liver imaging: MRI with CT correlationErsanAltun, Richard C.Semelka2015Abdominal-Pelvic MRIErsanAltun, Diego R.Martin, Richard C.Semelka2015The Role of Equilibrium and Kinetic Properties in the Dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to Physiological ConditionsZsoltBaranyai, ErnőBrücher, FulvioUggeri, AlessandroMaiocchi, ImreTóth, MelindaAndrási, AttilaGáspár, LászlóZékány, SilvioAime2015 | Chemistry - A European Journal, Vol. 21, No. 12Basic MR relaxation mechanisms and contrast agent designLuis M.De León-Rodríguez, André F.Martins, Marco C.Pinho, Neil M.Rofsky, A. DeanSherry2015 | Journal of Magnetic Resonance Imaging, Vol. 42, No. 3Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3–5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or GadoteridolGillesSoulez, Daniel C.Bloomgarden, Neil M.Rofsky, Martin P.Smith, Hani H.Abujudeh, Desiree E.Morgan, Richard J.Lichtenstein, Mark L.Schiebler, Franz J.Wippold, CraigRusso, Matthew J.Kuhn, Kevin W.Mennitt, Jeffrey H.Maki, AlanStolpen, JohnsonLiou, Richard C.Semelka, Miles A.Kirchin, NingyanShen, GianpaoloPirovano, AlbertoSpinazzi2015 | American Journal of Roentgenology, Vol. 205, No. 3Gadolinium metallo nanocongregates as potential magnetosensors for detecting early stage cancersRanuDutta, Avinash C.Pandey2015 | Applied Physics Letters, Vol. 106, No. 17Ligand Design in Medicinal Inorganic ChemistryEdward S.O'Neill, Elizabeth J.New2014Single-Dose Gadobutrol in Comparison With Single-Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 TMoritzWildgruber, ThomasStadlbauer, MichaelRasper, AlexanderHapfelmeier, OttoZelger, Hans-HenningEckstein, MartinHalle, Ernst J.Rummeny, Armin M.Huber2014 | Investigative Radiology, Vol. 49, No. 11Development of nanoparticles for clinical useToreSkotland, Tore-GeirIversen, KirstenSandvig2014 | Nanomedicine, Vol. 9, No. 9The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical updateJean-MarcIdée, NathalieFretellier, CarolineRobic, ClaireCorot2014 | Critical Reviews in Toxicology, Vol. 44, No. 10Medical RadiologySameh K.Morcos2014Medical RadiologyHenrik S.Thomsen2014Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?Miguel F.Ferreira, André F.Martins, Catarina I. O.Martins, Paula M.Ferreira, ÉvaTóth, Tiago B.Rodrigues, DanielCalle, SebastianCerdan, PilarLópez-Larrubia, José A.Martins, Carlos F. G. C.Geraldes2013 | Contrast Media & Molecular Imaging, Vol. 8, No. 1Medical RadiologyDanielGolovko, ElizabethSutton, Heike E.Daldrup-Link2013Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumineMoritzWagner, ReneSchilling, PatrickDoeblin, AlexanderHuppertz, RenyLuhur, CarstenSchwenke, MartinMaurer, BerndHamm, MatthiasTaupitz, TahirDurmus2013 | European Radiology, Vol. 23, No. 1Biomaterials for Cancer TherapeuticsR.Zeineldin2013Is Macrocycle a Synonym for Kinetic Inertness in Gd(III) Complexes? Effect of Coordinating and Noncoordinating Substituents on Inertness and Relaxivity of Gd(III) Chelates with DO3A-like LigandsMiloslavPolasek, PeterCaravan2013 | Inorganic Chemistry, Vol. 52, No. 7X-ray-Computed Tomography Contrast AgentsHrvojeLusic, Mark W.Grinstaff2013 | Chemical Reviews, Vol. 113, No. 3MRI contrast agents: Basic chemistry and safetyDapengHao, TaoAi, FrankGoerner, XuemeiHu, Val M.Runge, MichaelTweedle2012 | Journal of Magnetic Resonance Imaging, Vol. 36, No. 5Contrast Media in Breast ImagingLuis F.Serrano, BrookeMorrell, AndrewMai2012 | Magnetic Resonance Imaging Clinics of North America, Vol. 20, No. 4Gadobutrol for Magnetic Resonance Imaging of Chronic Myocardial InfarctionTahirDurmus, ReneSchilling, PatrickDoeblin, AlexanderHuppertz, BerndHamm, MatthiasTaupitz, MoritzWagner2012 | Investigative Radiology, Vol. 47, No. 3Renal Imaging in Patients with Renal ImpairmentJason A.Poff, Elizabeth M.Hecht, ParvatiRamchandani2011 | Current Urology Reports, Vol. 12, No. 1A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessmentRalph P.Mason, DawenZhao, LiLiu, Mary LynnTrawick, Kevin G.Pinney2011 | Integrative Biology, Vol. 3, No. 4Functional Renal Imaging: New Trends in Radiology and Nuclear MedicineEmmanuelDurand, PhilippeChaumet-Riffaud, NicolasGrenier2011 | Seminars in Nuclear Medicine, Vol. 41, No. 1Quarter-Dose (0.025 mmol/kg) Gadobenate Dimeglumine for Abdominal MRI in Patients at Risk for Nephrogenic Systemic Fibrosis: Preliminary ObservationsRafael O. P.de Campos, VascoHeredia, MiguelRamalho, Marcos S.De Toni, AidaLugo-Somolinos, Edwin R.Fuller, Richard C.Semelka2011 | American Journal of Roentgenology, Vol. 196, No. 3The fate of Gd and chelate following intravenous injection of gadodiamide in ratsGrete MørkKindberg, SteinarUran, GreteFriisk, IvarMartinsen, ToreSkotland2010 | European Radiology, Vol. 20, No. 7Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisationM. M.Stollenwerk, I.Pashkunova-Martic, C.Kremser, H.Talasz, G. C.Thurner, A. A.Abdelmoez, E. A.Wallnöfer, A.Helbok, E.Neuhauser, N.Klammsteiner, L.Klimaschewski, E.Guggenberg, E.Fröhlich, B.Keppler, W.Jaschke, P.Debbage2010 | Histochemistry and Cell Biology, Vol. 133, No. 4Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticlesA. A.Abdelmoez, G. C.Thurner, E. A.Wallnöfer, N.Klammsteiner, C.Kremser, H.Talasz, M.Mrakovcic, E.Fröhlich, W.Jaschke, P.Debbage2010 | Histochemistry and Cell Biology, Vol. 134, No. 2MR peritoneography in the investigation of transdiaphragmatic leakage in a peritoneal dialysis patientYing-WeiWu, YiLin, Pei-XiangGu, Nan-XinHao2010 | European Journal of Radiology Extra, Vol. 76, No. 3New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imagingToreSkotland, Tore-GeirIversen, KirstenSandvig2010 | Nanomedicine: Nanotechnology, Biology and Medicine, Vol. 6, No. 6Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophagesBao-DiGou, ShaBian, Tian-LanZhang, KuiWang2010 | Toxicology in Vitro, Vol. 24, No. 6Nephrogenic Systemic Fibrosis: Report of an Additional Case With Granulomatous InflammationCaseyWilford, Jo-DavidFine, Alan SBoyd, SomaSanyal, Jerrold LAbraham, Sara MKantrow2010 | The American Journal of Dermatopathology, Vol. 32, No. 1Screening Patients to Assess Renal Function Before Administering Gadolinium Chelates: Assessment of the Choyke QuestionnaireBrena F.Sena, Julia P.Stern, Pari V.Pandharipande, BarbaraKlemm, JulieBulman, IvanPedrosa, Neil M.Rofsky2010 | American Journal of Roentgenology, Vol. 195, No. 2MR contrast agents: Applications in hepatobiliary imagingTanCher, JanioSzklaruk2010 | Applied RadiologyTargeted probes for cardiovascular MRIRitikaUppal, PeterCaravan2010 | Future Medicinal Chemistry, Vol. 2, No. 3Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy—Report from Two U.S. Universities1Ersan Altun, , Diego R. Martin, , Rebecca Wertman, , Aida Lugo-Somolinos, , Edwin R. Fuller, 3rd, , and Richard C. Semelka, 1 December 2009 | Radiology, Vol. 253, No. 3Classification and basic properties of contrast agents for magnetic resonance imagingCarlos F. G. C.Geraldes, SophieLaurent2009 | Contrast Media & Molecular Imaging, Vol. 4, No. 1Medical RadiologySameh K.Morcos2009Medical RadiologyHenrik S.Thomsen2009Principles of responsive lanthanide-based luminescent probes for cellular imagingAuroreThibon, Valérie C.Pierre2009 | Analytical and Bioanalytical Chemistry, Vol. 394, No. 1Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cellsLi-JuanFu, Jin-XiaLi, Xiao-GaiYang, KuiWang2009 | JBIC Journal of Biological Inorganic Chemistry, Vol. 14, No. 2Nephrogenic Systemic Fibrosis and Management of High-risk PatientsErsanAltun, Richard C.Semelka, CeylanCakit2009 | Academic Radiology, Vol. 16, No. 7Nephrogenic Systemic FibrosisJeffrey C. Weinreb, Phillip H.Kuo2009 | Magnetic Resonance Imaging Clinics of North America, Vol. 17, No. 1Molecular imaging with nanoparticles: giant roles for dwarf actorsPaulDebbage, WernerJaschke2008 | Histochemistry and Cell Biology, Vol. 130, No. 5Nephrogenic Systemic Fibrosis: Considerations for the CardiologistNeil M.Rofsky2008 | JACC: Cardiovascular Imaging, Vol. 1, No. 4Update on Nephrogenic Systemic FibrosisHenrik S.Thomsen, PeterMarckmann, Vibeke B.Logager2008 | Magnetic Resonance Imaging Clinics of North America, Vol. 16, No. 4Implications of NSF-Active and NSF-Inert in Nephrogenic Systemic FibrosisClark D.Wiginton2008 | American Journal of Roentgenology, Vol. 191, No. 6Recommended Articles Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat ModelRadiology2018Volume: 290Issue: 2pp. 340-348Gadolinium Retention and Deposition Revisited: How the Chemical Properties of Gadolinium-based Contrast Agents and the Use of Animal Models Inform Us about the Behavior of These Agents in the Human BrainRadiology2017Volume: 285Issue: 3pp. 721-724Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine ModelRadiology2016Volume: 282Issue: 3pp. 734-742Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero ExposureRadiology2017Volume: 286Issue: 1pp. 122-128Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s PrimerRadioGraphics2019Volume: 40Issue: 1pp. 153-162See More RSNA Education Exhibits Gadolinium Washout: Is it Real?Digital Posters2019Practical Approaches and Updated Topics in Gadoxetate-Enhanced MR Imaging of the Liver: What the Radiologists Should KnowDigital Posters2019Gadolinium In Pediatric Magnetic Resonance: Indications, Risks And AlternativesDigital Posters2021 RSNA Case Collection Hip Polyethylene Liner DissociationRSNA Case Collection2021Osteoid osteoma of the femurRSNA Case Collection2022Parasagittal meningiomaRSNA Case Collection2022 Vol. 247, No. 3 Metrics Altmetric Score PDF download" @default.
• W2169314809 created "2016-06-24" @default.
• W2169314809 creator A5018711422 @default.
• W2169314809 creator A5039095005 @default.
• W2169314809 creator A5086139759 @default.
• W2169314809 date "2008-06-01" @default.
• W2169314809 modified "2023-10-17" @default.
• W2169314809 title "Nephrogenic Systemic Fibrosis: A Chemical Perspective" @default.
• W2169314809 cites W1966487765 @default.
• W2169314809 cites W1981583319 @default.
• W2169314809 cites W1986279630 @default.
• W2169314809 cites W1993638883 @default.
• W2169314809 cites W2010191338 @default.
• W2169314809 cites W2024317044 @default.
• W2169314809 cites W2033503179 @default.
• W2169314809 cites W2034215743 @default.
• W2169314809 cites W2044957933 @default.
• W2169314809 cites W2049134111 @default.
• W2169314809 cites W2056547807 @default.
• W2169314809 cites W2059283030 @default.
• W2169314809 cites W2066801370 @default.
• W2169314809 cites W2077643391 @default.
• W2169314809 cites W2096819922 @default.
• W2169314809 cites W2103813652 @default.
• W2169314809 cites W2104233131 @default.
• W2169314809 cites W2108281282 @default.
• W2169314809 cites W2112942188 @default.
• W2169314809 cites W2119489822 @default.
• W2169314809 cites W2136421454 @default.
• W2169314809 cites W2157433411 @default.
• W2169314809 cites W2171633513 @default.
• W2169314809 cites W4242230604 @default.
• W2169314809 doi "https://doi.org/10.1148/radiol.2473071975" @default.
• W2169314809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18487530" @default.
• W2169314809 hasPublicationYear "2008" @default.
• W2169314809 type Work @default.
• W2169314809 sameAs 2169314809 @default.
• W2169314809 citedByCount "72" @default.
• W2169314809 countsByYear W21693148092012 @default.
• W2169314809 countsByYear W21693148092013 @default.
• W2169314809 countsByYear W21693148092014 @default.
• W2169314809 countsByYear W21693148092015 @default.
• W2169314809 countsByYear W21693148092016 @default.
• W2169314809 countsByYear W21693148092017 @default.
• W2169314809 countsByYear W21693148092018 @default.
• W2169314809 countsByYear W21693148092019 @default.
• W2169314809 countsByYear W21693148092020 @default.
• W2169314809 countsByYear W21693148092021 @default.
• W2169314809 countsByYear W21693148092022 @default.
• W2169314809 crossrefType "journal-article" @default.
• W2169314809 hasAuthorship W2169314809A5018711422 @default.
• W2169314809 hasAuthorship W2169314809A5039095005 @default.
• W2169314809 hasAuthorship W2169314809A5086139759 @default.
• W2169314809 hasConcept C126838900 @default.
• W2169314809 hasConcept C12713177 @default.
• W2169314809 hasConcept C142724271 @default.
• W2169314809 hasConcept C143409427 @default.
• W2169314809 hasConcept C154945302 @default.
• W2169314809 hasConcept C2780559512 @default.
• W2169314809 hasConcept C2781027423 @default.
• W2169314809 hasConcept C41008148 @default.
• W2169314809 hasConcept C71924100 @default.
• W2169314809 hasConceptScore W2169314809C126838900 @default.
• W2169314809 hasConceptScore W2169314809C12713177 @default.
• W2169314809 hasConceptScore W2169314809C142724271 @default.
• W2169314809 hasConceptScore W2169314809C143409427 @default.
• W2169314809 hasConceptScore W2169314809C154945302 @default.
• W2169314809 hasConceptScore W2169314809C2780559512 @default.
• W2169314809 hasConceptScore W2169314809C2781027423 @default.
• W2169314809 hasConceptScore W2169314809C41008148 @default.
• W2169314809 hasConceptScore W2169314809C71924100 @default.
• W2169314809 hasIssue "3" @default.
• W2169314809 hasLocation W21693148091 @default.
• W2169314809 hasLocation W21693148092 @default.
• W2169314809 hasOpenAccess W2169314809 @default.
• W2169314809 hasPrimaryLocation W21693148091 @default.
• W2169314809 hasRelatedWork W2071182757 @default.
• W2169314809 hasRelatedWork W2073177925 @default.
• W2169314809 hasRelatedWork W2097614368 @default.
• W2169314809 hasRelatedWork W2104738562 @default.
• W2169314809 hasRelatedWork W2135415672 @default.
• W2169314809 hasRelatedWork W2369718642 @default.
• W2169314809 hasRelatedWork W2413522784 @default.
• W2169314809 hasRelatedWork W2767418652 @default.
• W2169314809 hasRelatedWork W2118652395 @default.
• W2169314809 hasRelatedWork W2185536823 @default.
• W2169314809 hasVolume "247" @default.
• W2169314809 isParatext "false" @default.
• W2169314809 isRetracted "false" @default.
• W2169314809 magId "2169314809" @default.
• W2169314809 workType "article" @default.